May 29, 2018
Akers withdraw its application for PIFA CHlamydia AKR.L
Akers Biosciences has decided to withdaw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with…
Pharmaceuticals, Biotechnology and Life Sciences
Akers Biosciences has decided to withdaw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with…